[Molecular action mechanisms of the therapeutic agents for kidney diseases: Glucocorticoid hormone and its receptor].
Imai
Hirokazu
H
Division of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University School of Medicine.
Kitagawa
Wataru
W
D000284:Administration, Oral; D000242:Cyclic AMP / Q000378:metabolism; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D006360:Heat-Shock Proteins; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis / Q000235:genetics; D007674:Kidney Diseases / Q000188:drug therapy*; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D016328:NF-kappa B / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000378:metabolism; D020551:Pulse Therapy, Drug; D011965:Receptors, Glucocorticoid / Q000145:classification / Q000502:physiology
D005938:Glucocorticoids; D006360:Heat-Shock Proteins; D007376:Interleukin-2; D016328:NF-kappa B; D016760:Proto-Oncogene Proteins c-fos; D016755:Proto-Oncogene Proteins c-jun; D011965:Receptors, Glucocorticoid; D000242:Cyclic AMP; D020928:Mitogen-Activated Protein Kinases